MAIT cell activation augments adenovirus vector vaccine immunogenicity.
Saved in:
| Title: | MAIT cell activation augments adenovirus vector vaccine immunogenicity. |
|---|---|
| Authors: | Provine NM; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK. nicholas.provine@ndm.ox.ac.uk paul.klenerman@ndm.ox.ac.uk., Amini A; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Garner LC; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Spencer AJ; Jenner Institute, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Hutchings C; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Silva Reyes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., FitzPatrick MEB; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Chinnakannan S; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Oguti B; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Raymond M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Ulaszewska M; Jenner Institute, University of Oxford, Oxford, UK., Troise F; Nouscom, SRL, Rome, Italy.; Ceinge Biotechnologie Avanzate, Naples, Italy., Sharpe H; Jenner Institute, University of Oxford, Oxford, UK., Morgan SB; Respiratory Medicine Unit, Nuffield Department of Medicine - Experimental Medicine, University of Oxford, Oxford, UK., Hinks TSC; Respiratory Medicine Unit, Nuffield Department of Medicine - Experimental Medicine, University of Oxford, Oxford, UK., Lambe T; Jenner Institute, University of Oxford, Oxford, UK., Capone S; ReiThera, SRL, Rome, Italy., Folgori A; ReiThera, SRL, Rome, Italy., Barnes E; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Jenner Institute, University of Oxford, Oxford, UK.; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Rollier CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Klenerman P; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK. nicholas.provine@ndm.ox.ac.uk paul.klenerman@ndm.ox.ac.uk.; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. |
| Source: | Science (New York, N.Y.) [Science] 2021 Jan 29; Vol. 371 (6528), pp. 521-526. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
